Top challenges in cancer care in the 3rd decade of the 21st century

Clicks: 2
ID: 311759
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #615 of 631 articles by views in science and technology of advanced materials

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 631 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

At the beginning of 2020, just before the wide spread of news about the COVID-19 pandemic, Professor David Collingridge, editor-in-chief of Lancet Oncology, and the senior editor Katherine Gourd asked some of the members of the Lancet Oncology International Advisory Board to send their thoughts, focusing on the top three challenges and opportunities in global cancer control over the next ten years. What we cite here is inspired by the reply of Ahmed Elzawawy to the request from Lancet Oncology.

Reference Key
persistent_1771692038_6999e006037c6 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Eduardo Cazap
Journal science and technology of advanced materials
Year 2022
DOI
10.1088/978-0-7503-3075-6ch6
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.